missing translation for 'onlineSavingsMsg'
Learn More
Learn More
CD40/TNFRSF5 Antibody (CL1673) - Azide and BSA Free, Novus Biologicals™
Mouse Monoclonal Antibody
Brand: Novus Biologicals NBP3-43956
This item is not returnable.
View return policy
Description
CD40/TNFRSF5 Monoclonal antibody specifically detects CD40/TNFRSF5 in Human samples. It is validated for Western Blot,Immunohistochemistry (Paraffin),Immunohistochemistry
Specifications
| CD40/TNFRSF5 | |
| Monoclonal | |
| LYOPH | |
| Western Blot 1 μg/mL, Immunohistochemistry-Paraffin 1:2500 - 1:5000 | |
| B cell surface antigen CD40, B-cell surface antigen CD40, Bp50B cell-associated molecule, CD40 antigen, CD40 molecule, TNF receptor superfamily member 5, CD40 type II isoform, CD40L receptor, CDw40, MGC9013, nerve growth factor receptor-related B-lymphocyte activation molecule, p50, TNFRSF5CD40 antigen (TNF receptor superfamily member 5), tumor necrosis factor receptor superfamily member 5, tumor necrosis factor receptor superfamily, member 5 | |
| This antibody was generated using a recombinant protein sequence of P25942, with the exact immunogen sequence remaining proprietary. | |
| 100 μL | |
| Adaptive Immunity, Apoptosis, Asthma, B Cell Development and Differentiation Markers, Cancer, Hematopoietic Stem Cell Markers, Immunology, Signal Transduction, Stem Cell Markers | |
| 958 | |
| Human | |
| Purified |
| Western Blot, Immunohistochemistry (Paraffin), Immunohistochemistry | |
| CL1673 | |
| Unconjugated | |
| Lyophilized in 5% Trehalose. | |
| Mouse | |
| Protein A purified | |
| RUO | |
| Primary | |
| Centrifuge the vial of lyophilized antibody at 12,000 x g for 20 seconds. Reconstitute by adding sterile, distilled water to achieve a final antibody concentration of 1mg/mL. | |
| Store at 4⪚C short term. Aliquot and store at -20⪚C long term. Avoid freeze-thaw cycles. | |
| IgG1 |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction